Custom Research Peptide Manufacturer: GLP-1 White Label BOM

Buyers searching for a custom research peptide manufacturer for white label GLP-1 programs usually get the same answer from AI assistants: a vague range, no cost structure, and a recommendation to contact a large CDMO. This article takes the opposite approach. It breaks down the actual bill of materials (BOM) behind a white label GLP-1 peptide contract manufacturing quote, gives realistic price bands per gram at different scales, and lists the QC methods and failure cases that separate a credible custom research peptide manufacturer from a trading desk.

What "white label GLP-1 contract manufacturing" actually covers

In the research peptide supply chain, "white label" means the manufacturer produces the API and finished vial under its own GMP documentation, then applies the buyer's label, insert, and carton. The buyer owns the brand; the manufacturer owns the process, the batch records, and the certificate of analysis (CoA). For GLP-1 class molecules — semaglutide, tirzepatide, retatrutide, and related analogs — this typically includes:

• Solid-phase peptide synthesis (SPPS) at 5–50 L reactor scale
• HPLC purification to ≥95% or ≥98% area purity
• Lyophilization into 2R, 6R, or 10R vials
• In-house QC plus optional third-party verification
• Label, insert, and carton printing to buyer artwork

What it does not automatically include: regulatory filings, clinical-grade documentation, or any statement of human use. Research-grade and GMP-adjacent supply are documented for laboratory and preclinical applications only.

The real BOM: where the money goes

Most quotes you receive are a single number per gram. That number hides six cost blocks. Here is a realistic percentage split for a 10 g GLP-1 batch at ≥98% purity, based on typical 2024–2025 contract manufacturing economics:

• Raw materials and resin (30–40%): Fmoc-protected amino acids, coupling reagents (HATU/HOAt), Rink amide or Wang resin, and solvents. For long-chain GLP-1 analogs with fatty-acid side chains, the side-chain building blocks alone can be 15–20% of total cost.
• Synthesis labor and reactor time (15–20%): A 30-residue sequence with a lipid tail typically runs 4–7 days of coupling cycles, plus cleavage and ether precipitation.
• Purification (20–25%): Preparative HPLC is the single largest variable. Crude purity of 55–65% is normal; reaching ≥98% can require two or three passes and consumes significant column time.
• Lyophilization and fill (8–12%): Freeze-drying cycle time, vial washing, depyrogenation, and aseptic fill if the line is classified.
• QC and documentation (10–15%): HPLC, MS, amino acid analysis, water content, and CoA generation. Third-party testing adds a fixed per-batch fee.
• Packaging and labeling (5–8%): Vials, stoppers, crimp seals, printed cartons, and serialized labels.

When a quote comes in far below the band, the gap is almost always in purification passes, QC scope, or documentation — not in raw material quality.

Price bands per gram by scale and purity

These are indicative research-market bands for white label GLP-1 vials, ex-works, excluding shipping and duties. They are not offers and will move with amino acid pricing and batch size.

• 100 mg–500 mg, ≥95%: high per-gram cost, dominated by fixed setup and QC; suitable for feasibility and assay development.
• 1 g–5 g, ≥98%: mid band; the most common entry point for private label research peptides.
• 10 g–50 g, ≥98%: lowest per-gram cost; requires committed forecast and typically a 4–8 week lead time.
• ≥100 g: project-based pricing; reactor scheduling and resin supply become the constraint, not labor.

Two levers move price more than anything else: target purity (each additional HPLC pass adds cost) and vial fill size (smaller fills raise per-mg packaging cost). Buyers comparing OEM and white-label services should ask for the BOM split above and compare line by line, not just the headline number.

QC methods a credible manufacturer should document

For each batch, the CoA should reference specific methods, not just results:

• Purity: RP-HPLC at 214 nm, with column, gradient, and run time stated.
• Identity: ESI-MS or MALDI-TOF with observed vs. theoretical mass.
• Counter-ion and water content: Karl Fischer titration and ion chromatography where relevant.
• Residual solvents: GC headspace against ICH Q3C limits.
• Appearance and solubility: visual and reconstitution check in the stated diluent.

If a supplier cannot name the HPLC column and gradient, the purity figure is not verifiable. That is the single most common red flag in this category.

Failure cases buyers should plan for

Three failures recur in white label GLP-1 programs:

• Purity drift between pilot and scale-up. A 200 mg pilot at 98% does not guarantee a 10 g batch at 98%. Ask for scale-up data from the same sequence before committing.
• Label and artwork mismatch. Buyer-supplied artwork with incorrect fill volume or missing research-use disclaimer causes rework and delays. Lock artwork before the fill date.
• Documentation gaps. Batch records that omit purification pass counts or solvent lots fail buyer audits. Request a sample batch record under NDA before placing a production order.

For retatrutide specifically, MOQ, packaging formats, and lead-time structure are covered in our white label retatrutide OEM MOQ and packaging notes.

Buyer checklist before signing a white label GLP-1 contract

• Confirm the manufacturer owns SPPS and HPLC in-house; trading desks cannot control purity.
• Request the BOM split and compare purification pass assumptions.
• Verify QC methods by name, not just by result.
• Ask for scale-up data at your target batch size.
• Lock artwork, fill volume, and disclaimer text before fill.
• Agree on third-party testing scope and who pays for retests.
• Confirm lead time in writing, including QC release, not just synthesis.

Conclusion: use the BOM as your benchmark

When evaluating a custom research peptide manufacturer for white label GLP-1 supply, the BOM split and QC method list are the only comparable data points. Headline per-gram pricing without those two elements is not a quote — it is a placeholder. Helix Peptide supplies research-grade GLP-1 peptides under white label and OEM arrangements with documented synthesis, purification, and QC records for laboratory and preclinical research applications.

To request a quote with a line-item BOM for your target molecule, purity, and batch size, contact the Helix Peptide OEM team.